You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 15, 2025

Drug Price Trends for NDC 00955-1054


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00955-1054

Drug Name NDC Price/Unit ($) Unit Date
SEVELAMER 2.4 GM POWDER PACKET 00955-1054-90 2.00747 EACH 2024-07-17
SEVELAMER 2.4 GM POWDER PACKET 00955-1054-90 2.02319 EACH 2024-06-19
SEVELAMER 2.4 GM POWDER PACKET 00955-1054-90 2.05232 EACH 2024-05-22
SEVELAMER 2.4 GM POWDER PACKET 00955-1054-01 2.36984 EACH 2024-04-17
SEVELAMER 2.4 GM POWDER PACKET 00955-1054-90 2.36984 EACH 2024-04-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 00955-1054

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
SEVELAMER CARBONATE 2.4GM/PKT PWDR Sanofi Aventis U.S. LLC 00955-1054-90 90 60.23 0.66922 2023-06-01 - 2028-05-31 Big4
SEVELAMER CARBONATE 2.4GM/PKT PWDR Sanofi Aventis U.S. LLC 00955-1054-90 90 86.83 0.96478 2023-06-01 - 2028-05-31 FSS
SEVELAMER CARBONATE 2.4GM/PKT PWDR Sanofi Aventis U.S. LLC 00955-1054-90 90 16.95 0.18833 2024-01-01 - 2028-05-31 Big4
SEVELAMER CARBONATE 2.4GM/PKT PWDR Sanofi Aventis U.S. LLC 00955-1054-90 90 86.83 0.96478 2024-01-01 - 2028-05-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 00955-1054

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies a drug product. It includes the labeler code, product code, and package code, each providing specific information about the drug[4].

Identifying the Drug

The NDC 00955-1054 corresponds to a specific drug product. However, without direct access to the FDA's NDC Directory or other databases at the time of writing, we cannot identify the exact drug name and details directly from the NDC. Typically, this information would be retrieved from the FDA's National Drug Code Directory or similar databases[1][4].

Market Trends in Prescription Drugs

The overall prescription drug market is expected to experience significant growth. Here are some key trends that could influence the price projections for any prescription drug, including the one identified by NDC 00955-1054:

General Market Growth

The prescription drug market is projected to grow at a Compound Annual Growth Rate (CAGR) of 9% through 2030. This growth is driven by various factors, including an aging population, increased healthcare spending, and the development of new treatments[5].

Specialty Pharmaceuticals

Specialty pharmaceuticals, which include drugs for complex or chronic conditions such as cancer, infectious diseases, and autoimmune disorders, are a significant driver of market growth. These drugs often come with high price tags and are expected to see a 4.18% price increase, contributing to the overall market inflation[2].

Biosimilars

Biosimilars, which are biologic products that are highly similar to an already approved biologic product, are gaining market share. While they are expected to increase in price by only 0.55%, their adoption can impact the pricing dynamics of the original biologic drugs. For example, biosimilar adalimumab products are expected to gain market share, potentially affecting the prices of brand-name drugs like Humira[2].

Price Projections

Factors Influencing Price Increases

Drug prices are influenced by several factors, including research and development costs, shareholder obligations, rebates, and the use of co-pay assistance programs. Manufacturers often attribute price increases to these factors, which can range from 10% to approximately 20% annually[3].

Recent Price Trends

For a specific drug like the one identified by NDC 00955-1054, price trends would typically be analyzed based on historical data. Here is an example of how prices can fluctuate:

  • Historical Price Data: If available, historical price data would show the drug's price fluctuations over time. For instance, a drug like Linezolid (NDC 00054-0319) has seen price changes ranging from $1.82 to $1.95 per unit over a few months[5].

Projected Price Increases

Given the general trends in the prescription drug market, here are some possible projections:

  • Annual Increase: If the drug falls under the category of specialty pharmaceuticals or is a high-cost biologic, it could see an annual price increase similar to the projected 4.18% for specialty medications[2].
  • Market Competition: The presence of competitors, including generics or biosimilars, could mitigate price increases. However, if the drug is a brand-name product with limited competition, it might experience higher price increases[3].

Supply Chain and Regulatory Factors

FDA Regulations

The FDA's regulations and the drug's listing status in the NDC Directory can affect its market presence and pricing. For example, if the drug is listed under a specific marketing category, such as an "Outsourcing Facility Compounded Human Drug Product," it may have different regulatory requirements and pricing dynamics[1].

Supply Chain Management

Managing pharmacy expenditures and strengthening the supply chain are critical in controlling drug costs. Issues like drug shortages and rising costs can impact the pricing and availability of the drug[2].

Key Takeaways

  • Market Growth: The prescription drug market is expected to grow significantly, driven by specialty pharmaceuticals and new treatments.
  • Price Influencers: Factors such as R&D costs, shareholder obligations, and market competition influence drug price increases.
  • Regulatory Impact: FDA regulations and the drug's listing status can affect its market presence and pricing.
  • Supply Chain: Effective supply chain management is crucial in controlling drug costs and ensuring availability.

FAQs

Q: What is the National Drug Code (NDC) and how is it used? A: The NDC is a unique, three-segment number that identifies a drug product, including the labeler, product, and package code. It is used to track and manage drug products in the market[4].

Q: What drives the price increases in prescription drugs? A: Price increases are driven by factors such as research and development costs, shareholder obligations, rebates, and the use of co-pay assistance programs[3].

Q: How do biosimilars affect the pricing of biologic drugs? A: Biosimilars can reduce the prices of biologic drugs by increasing competition. However, their adoption and impact on pricing depend on various market and regulatory factors[2].

Q: What is the role of the FDA in regulating drug prices? A: The FDA does not directly regulate drug prices but ensures that drugs are listed and reported correctly through the NDC Directory. Regulatory compliance can influence the market presence and pricing of drugs[1].

Q: How can healthcare providers manage rising drug costs? A: Healthcare providers can manage rising drug costs through effective supply chain management, strengthening their contract portfolios, and leveraging market insights to make informed purchasing decisions[2].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals - Vizient, Inc.
  3. Prescription Drug Price Transparency Results and Recommendations - Oregon Department of Consumer and Business Services
  4. National Drug Code Database Background Information - FDA
  5. Latest drug prices and trends for NDC 00054-0319 - DrugPatentWatch

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.